+766.2%
MRNA vs GLDM
-6.3%
+772.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GLDM | Excess | Alpha |
|---|---|---|---|---|
| 1D | -7.0% | -2.8% | -4.2% | -2.5% |
| 7D | -4.2% | -5.5% | +1.3% | +5.1% |
| 30D | +7.0% | -7.0% | +14.0% | +20.8% |
| 3M | +263.4% | -12.3% | +275.6% | +354.9% |
| 6M | +334.3% | -17.9% | +352.2% | +460.8% |
| YTD | +684.5% | -10.3% | +694.8% | +903.0% |
| 1Y | +766.2% | -7.8% | +773.9% | +953.9% |
| All | +766.2% | -6.3% | +772.5% | +953.9% |
Cumulative growth
Daily Returns
Daily percentage return beside GLDM.
Daily Out/Under-Performance
Portfolio return minus GLDM return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GLDM return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GLDM wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling